Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cenovus Energy Inc (CVE) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Cenovus Energy IncTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Cenovus Energy Inc vs Zimmer Biomet Holdings Inc — how do they compare? Cenovus Energy Inc trades at $30.22 (market cap $55.00B), while Zimmer Biomet Holdings Inc trades at $97.12 (market cap $18.55B). The key difference: Cenovus Energy Inc is far larger — about 3× Zimmer Biomet Holdings Inc's market cap, and Cenovus Energy Inc pays the higher dividend (2.09%). Which is the better fit depends on your goals.

CVEZBH
Market Cap
$55.00B$18.55B
Sector
EnergyHealth
52-Week High
$31.80$107.71
52-Week Low
$14.83$79.58
Enterprise Value
$61.08B$25.61B
Dividend Yield
2.09%0.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cenovus Energy Inc

Cenovus Energy (CVE) trades at $30.14, up 1.96% with bullish technical signals and strong fundamentals. The stock shows robust earnings momentum with recent quarterly beats, supported by record oil sands production and disciplined cost management. Valuation metrics remain attractive with P/E of 11.56 and EV/EBITDA of 5.77, while profitability metrics include 11.48% net income margin and 20.96% ROE. Recent news highlights institutional buying interest and strong Q2 2026 operational performance.

CVE presents a compelling investment case with undervalued metrics and positive earnings trajectory, though exposure to volatile oil prices and refining margins poses risks. Analyst consensus leans bullish with 40.7% buy ratings, while technical indicators suggest continued upward momentum. The company's integrated model and growth projects support long-term value creation for shareholders.

Zimmer Biomet Holdings Inc

ZBH trades at $96.04, down 1.78% today, with a bullish technical signal from moving averages and a consensus analyst price target of $103.56. Recent Q2 2026 earnings beat expectations with EPS of $2.07 versus $2.01 expected, and the company raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23 billion and a net income margin of 8.56%.

The outlook is positive given earnings momentum and raised guidance, but risks include competitive pressures and debt levels, with the debt-to-asset ratio rising to 32.57% in 2025. Analyst sentiment is mixed with 40% buy ratings, offering a potential 7.8% upside to the consensus target, though investors should monitor margin trends and debt management.

Returns comparison

Trailing returns across standard periods

About Cenovus Energy Inc

Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.

Read more on CVE

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH